Posted at 20:29h
Testosterone Treatment and Prostate Cancer Risk: A review of a recent study on the safety of long-term treatment.
in ESA Blog
By Shawn Blick, MD
Despite the well-proven benefits for testosterone replacement therapy (TRT), physicians are still fearful that testosterone may cause the progression of undiagnosed prostate cancer (PCa) or its development with advancing age. This is despite the evidence from several published reviews (Morgentaler and Roddam et al.), suggesting that the concept above is a “myth”. Similarly, Shabsigh et al. concluded from an extensive analysis of 44 studies that “none” demonstrated that TRT for hypogonadism increased prostate cancer risk or increased the Gleason grade of cancer detected in treated vs. untreated men.